Advertisement
Skip to Content

Baxter International Inc BAX Stock Quote

| Rating as of

NYSE: BAX

Last close prices updated as of Feb 06, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 45.16
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Investment Style Mid Value
  • Day Range 45.13  –  46.66
  • Year Range 43.99  –  89.70
  • Market Cap 22.7661 Bil
  • Volume / Avg 3.9 Mil /  5.1 Mil
  • Price / Sales 1.54
  • Price / Book 4.11
  • Forward Div Yield 2.57%
  • Trailing Div Yield 2.55%

Morningstar‘s Stock Analysis BAX

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Baxter Announces Renal Spinoff to Unlock Value in Discounted Shares

Julie Utterback Senior Equity Analyst

Analyst Note

| Julie Utterback |

As previously signaled, Baxter unveiled divestiture plans, including spinning off its kidney care businesses (renal care and acute care segments that represent roughly 30% of Baxter sales) within the next 12-18 months and exploring strategic alternatives for its BioPharma Solutions business (about 5% of sales) that provides contract manufacturing services and has limited synergies with its other operations. Given that the value of the kidney spinoff will represent nearly all the value of these planned divestitures and flow directly to shareholders tax free, we expect to maintain our $85 fair value estimate for the combined entity at first glance. Despite the Jan. 6 share movement, we think these actions to increase strategic focus through divestitures and then improve underlying execution suggest a desire to unlock shareholder value and reinforce our Exemplary capital allocation rating. Also, considering recent share prices well below the full entity's intrinsic value, we think long-term investors should consider share weakness as an opportunity to invest in this narrow-moat medical supplier at a cheap price.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics BAX

Company Profile BAX

Business Description

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. The company offers contract manufacturing services to pharmaceutical companies. The Hillrom transaction has added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's 2021 revenue came from more digitally connected offerings like its smart beds and Voalte medical communications app.

Contact
One Baxter Parkway
Deerfield, IL, 60015
Industry Medical Instruments & Supplies
Employees 60,000

Related Articles BAX

FAQs for Baxter International Inc Stock

Yes. BAX has a forward dividend yield of 2.57%. See BAX’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

BAX’s market cap is 22.77 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

BAX’s stock style is Mid Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

BAX’s price/sales is 1.54.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

BAX’s price/forward earnings is 12.24.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

BAX’s price/book is 4.11.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See BAX’s valuation ratios compared to the Market Index.

BAX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare BAX’s historical performance against its industry peers and the overall market.